In Alzheimer’s, should EEG be used as a functional biomarker when evaluating treatment efficacy? [Video]

Read more here: https://xtalks.com/in-alzheimers-dementia-should-eeg-be-used-as-a-functional-biomarker-of-target-engagement-and-organizational-change-when-evaluating-treatment-efficacy-3788

Xtalks spoke with CJ Barnum, PhD, VP of CNS Development at INmune Bio and Brian Murphy, PhD, Co-Founder and Chief Scientific Officer of Cumulus Neuroscience to gain insights into the utility of EEG biomarkers in clinical studies evaluating new Alzheimer’s disease treatments.

Dr. Barnum shared results of a pilot study conducted by INmune Bio in which use of the Cumulus Neuroassessment Platform demonstrated the potential of EEG as a functional biomarker that can help reveal whether biological changes after a treatment result in improved brain function.

Dr. Barnum and Dr. Murphy explain how EEG biomarkers can offer a deeper understanding of Alzheimer’s disease progression and treatment efficacy.

#alzheimers #biomarkers #eeg